Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) A randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial [Erforschung der Wirksamkeit und Sicherheit einer oralen Gabe von Pirfenidon bei progressiven, nicht-IPF Lungenfibrosen (RELIEF) Eine randomisierte, doppelblinde, Placebo kontrollierte, Parallelgruppen, multizentrische, Phase-II-Studie]

Next Previous
X
Search
Trial Profile

Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) A randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial [Erforschung der Wirksamkeit und Sicherheit einer oralen Gabe von Pirfenidon bei progressiven, nicht-IPF Lungenfibrosen (RELIEF) Eine randomisierte, doppelblinde, Placebo kontrollierte, Parallelgruppen, multizentrische, Phase-II-Studie]

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2019

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Extrinsic allergic alveolitis; Pulmonary fibrosis; Respiration disorders
  • Focus Therapeutic Use
  • Acronyms RELIEF

    • Most Recent Events

    • 10 Nov 2019 Status changed from discontinued to completed.
    • 06 Jul 2018 Status changed from suspended to discontinued.
    • 05 May 2018 Status changed from recruiting to suspended.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top